KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Capital Leases (2019 - 2024)

Historic Capital Leases for Biolife Solutions (BLFS) over the last 6 years, with Q3 2024 value amounting to $913000.0.

  • Biolife Solutions' Capital Leases fell 2696.0% to $913000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $913000.0, marking a year-over-year decrease of 2696.0%. This contributed to the annual value of $1.2 million for FY2023, which is 81904.76% up from last year.
  • As of Q3 2024, Biolife Solutions' Capital Leases stood at $913000.0, which was down 2696.0% from $996000.0 recorded in Q2 2024.
  • In the past 5 years, Biolife Solutions' Capital Leases ranged from a high of $1.3 million in Q2 2023 and a low of $12000.0 during Q4 2020
  • Its 5-year average for Capital Leases is $556312.5, with a median of $322500.0 in 2021.
  • Its Capital Leases has fluctuated over the past 5 years, first surged by 232500.0% in 2021, then plummeted by 6245.06% in 2023.
  • Biolife Solutions' Capital Leases (Quarter) stood at $12000.0 in 2020, then surged by 2325.0% to $291000.0 in 2021, then crashed by 56.7% to $126000.0 in 2022, then surged by 819.05% to $1.2 million in 2023, then decreased by 21.16% to $913000.0 in 2024.
  • Its Capital Leases was $913000.0 in Q3 2024, compared to $996000.0 in Q2 2024 and $1.1 million in Q1 2024.